133 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
18 Oct 23
Current report (foreign)
6:21am
a tax assessment related to the treatment of an acquisition break fee received by Shire plc (“Shire”) in October 2014 from AbbVie Inc. (“AbbVie”), for EUR … 130 million, resulting in a tax expense reduction of approximately JPY 63 billion for Takeda. On November 28, 2018, Shire received a tax assessment
6-K
TAK
Takeda Pharmaceutical Co
2 Aug 21
Current report (foreign)
6:15am
Number
Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie
SIGNATURES … Officer and Corporate Controller
News Release
Takeda Receives Decision by the Irish Tax Appeals Commission Relating to
Tax Assessment on Break Fee
6-K
TAK
Takeda Pharmaceutical Co
1 Sep 21
Current report (foreign)
8:01am
of the root cause of the particles and the corrective and preventive actions being taken;
An assessment of the nature of a particle from one vial from Lot … 3004667; and
An associated medical safety assessment, to determine if the identified particle poses a health or safety risk.
Root Cause Investigation
6-K
TAK
Takeda Pharmaceutical Co
26 Oct 23
Current report (foreign)
6:20am
to a tax assessment related to the treatment of an acquisition break fee Shire received from AbbVie, Inc. (AbbVie) in 2014 as well as lower pretax … for the amount of JPY 63.5 billion, which resulted from a settlement with the Irish Revenue Commissioners over the tax assessment of an acquisition
6-K
EX-4.9
TAK
Takeda Pharmaceutical Co
9 Jul 20
Current report (foreign)
10:27am
, assessment, fee or other governmental charge so withheld or deducted from the Japanese taxing authority imposing such tax, duty, assessment, fee or other … not apply to (A) any estate, inheritance, gift, sales, transfer, personal property or any similar tax, duty, assessment, fee or other governmental
6-K
EX-4.6
kyzhga5bs0mvp9
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.4
gybcpf8ymq riwtb3ccz
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.7
jlt5bxeh3q0u4eaui
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-99.1
idvapomexqlpx qtwxer
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
6-K
hr0kw1
1 Oct 21
Current report (foreign)
6:03am
6-K
EX-4.2
je0ol nedfhy6egbhqs
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-99.1
t1ohyxplp5s
31 May 22
Current report (foreign)
12:00am
6-K
7awoawlh3terw
1 Feb 24
Current report (foreign)
6:06am
6-K
EX-99.1
49sxl0rg5vjl
28 May 21
Current report (foreign)
6:03am
6-K
EX-4.3
ggut9dm02we ktuxi
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.5
9mjsbdm6myu f139a
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-4.8
rrz2aoh5pwwsdj8hh
9 Jul 20
Current report (foreign)
10:27am
6-K
EX-99.1
g0525mphj7c 63nuif
27 Oct 22
Current report (foreign)
6:01am
6-K
4a89 mozy7nqjkv0o
11 Sep 23
Current report (foreign)
6:50am
6-K
EX-99.1
1c1 jfsb2p
11 May 23
Current report (foreign)
6:07am